Study guide
11.5 Cardiopulmonary & Airway Emergencies
Advanced Oncology Certified Nurse Practitioner AOCNP
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 About the AOCNP Exam 1.2 How to Use This AOCNP Study Guide
2 Chapter 2: Cancer Continuum - Risk, Prevention & Screening
2.1 Cancer Risk Factors, At-Risk Populations & Health Disparities 2.2 Primary Prevention, Vaccination, Chemoprevention & Risk-Reducing Surgery 2.3 Cancer Screening & Early Detection Guidelines 2.4 Screening for Subsequent & Second Primary Malignancies 2.5 Hereditary Cancer Syndromes & Genetic Counseling
3 Chapter 3: Cancer Continuum - Assessment, Diagnosis & Staging
3.1 Diagnostic Workup, Tissue Biopsy & Biomarker Evaluation 3.2 Pathology Interpretation, Histology & Tumor Grading 3.3 Cancer Staging Systems (TNM) & Prognostication Models 3.4 Performance Status, Frailty & Geriatric Assessment
4 Chapter 4: Cancer Continuum - Planning, Coordination & Survivorship
4.1 Established Guidelines for Care & Categories of Evidence 4.2 Individualized Treatment Planning & Molecular Tumor Boards 4.3 Reproductive Planning & Fertility Preservation 4.4 Patient Navigation & Interprofessional Care Coordination 4.5 Survivorship Care Planning & Late Effects Management 4.6 Post-Treatment Surveillance for Cancer Recurrence
5 Chapter 5: Cancer Treatment - Antineoplastic Pharmacology & Chemotherapy
5.1 Antineoplastic Principles, Dosing & Dose Adjustments 5.2 Cytotoxic Chemotherapy Classes & Adverse Effect Management 5.3 Safe Administration, Handling & Infusion Toxicities 5.4 Oral Antineoplastic Therapy: Adherence, Interactions & Monitoring
6 Chapter 6: Cancer Treatment - Targeted, Immuno & Hormonal Therapies
6.1 Targeted Therapies, Tyrosine Kinase Inhibitors & ADCs 6.2 Cancer Immunotherapy, Checkpoint Inhibitors & CAR T-Cell Therapy 6.3 Endocrine & Hormonal Therapies in Oncology
7 Chapter 7: Cancer Treatment - Radiation, Surgery, Regional & Multimodal Therapy
7.1 Radiation Oncology Principles & Toxicity Management 7.2 Surgical Oncology, Perioperative Care & Reconstruction 7.3 Regional & Localized Therapy Administration 7.4 Multimodal Therapy & Treatment Sequencing 7.5 Complementary, Alternative & Integrative Therapies
8 Chapter 8: Cancer Treatment - Transplantation, Clinical Trials & Response
8.1 Hematopoietic Stem Cell Transplantation (HSCT) & Cell Therapy 8.2 Clinical Trials, Research Protocols & Response Evaluation (RECIST)
9 Chapter 9: Supportive Care - Pain & Controlled Substance Safety
9.1 Cancer Pain Assessment & Comprehensive Analgesic Management 9.2 Controlled Substance Safety & Opioid Stewardship 9.3 Nonpharmacologic & Integrative Symptom Interventions
10 Chapter 10: Supportive Care - Symptom & Comorbidity Management
10.1 Acute, Late & Long-Term Patterns of Treatment-Related Symptoms 10.2 Gastrointestinal Symptom Management (CINV, Mucositis, Diarrhea) 10.3 Hematologic & Neurologic Toxicity Management 10.4 Dermatologic, Metabolic & Fatigue Management 10.5 Cancer-Associated Thrombosis & Anticoagulation 10.6 Comorbid Conditions & Their Interaction With Cancer Treatment 10.7 Palliative Care, Hospice & End-of-Life Management
11 Chapter 11: Oncologic Emergencies
11.1 Superior Vena Cava Syndrome & Structural Emergencies 11.2 Spinal Cord Compression & Neurologic Emergencies 11.3 Metabolic Emergencies: Tumor Lysis Syndrome & Hypercalcemia of Malignancy 11.4 Febrile Neutropenia, Sepsis & Vesicant Extravasation 11.5 Cardiopulmonary & Airway Emergencies 11.6 Hematologic & Endocrine Emergencies: DIC, Leukostasis, Hyperviscosity & SIADH
12 Chapter 12: Psychosocial Issues
12.1 Psychosocial Assessment & Distress Screening in Oncology 12.2 Risk Factors & At-Risk Oncology Populations 12.3 Psychosocial & Emotional Sequelae of Disease and Treatment 12.4 Psychiatric & Psychosocial Comorbidities in Cancer Care 12.5 Caregiver Burden, Support & Community Resources
13 Chapter 13: Professional Practice & Roles of the APRN
13.1 APRN Scope of Practice, Prescriptive Authority & Standards of Care 13.2 Bioethics, Informed Consent & Quality Improvement in Oncology 13.3 Cultural Competence, Implicit Bias & Equitable Oncology Care 13.4 Accreditation Standards & Outcomes of APRN Practice 13.5 Competency Evaluation, Peer Review & Peer Education
11.5 Cardiopulmonary & Airway Emergencies
Key Takeaways Explain This Topic AI
Cardiac tamponade is a clinical diagnosis supported by Beck's triad and pulsus paradoxus greater than 10 mmHg, confirmed by echocardiography showing right atrial systolic and right ventricular diastolic collapse, and treated with urgent pericardiocentesis.
Diuretics and vasodilators are harmful in tamponade because the obstructed ventricle depends on preload; volume support and urgent drainage are the correct actions.
Massive hemoptysis is managed by positioning the patient with the bleeding lung dependent to protect the unaffected lung, securing the airway, and arranging urgent bronchoscopy or bronchial artery embolization.
Carotid blowout syndrome in a head and neck cancer patient with prior radiation or flap necrosis requires direct pressure, large-bore access, blood products, and emergent interventional radiology embolization or stenting.
No more than approximately 1.5 liters should be removed at a single thoracentesis, and drainage should stop earlier if chest tightness or cough develops, to avoid re-expansion pulmonary edema.
Last updated: August 2026
11.5 Cardiopulmonary & Airway Emergencies
Blueprint focus: ONCC Domain III.A, III.B, and III.C applied to the cardiothoracic emergencies. Every item below is tested the same way: recognize the syndrome, name the confirmatory test, and choose the immediate intervention.
1. Malignant Pericardial Effusion and Cardiac Tamponade
Etiology. Tumor invasion of the pericardium or obstruction of pericardial lymphatic drainage. Lung and breast carcinoma, melanoma, lymphoma, and leukemia account for most cases. Radiation to a mediastinal field can also produce effusion or constriction years later.
Pathophysiology. Fluid accumulating faster than the pericardium can stretch raises intrapericardial pressure above right-sided diastolic filling pressures. Chambers collapse in diastole, stroke volume falls, and cardiac output collapses. Rate of accumulation matters more than volume — 200 mL accumulating over hours can cause tamponade while 1,000 mL accumulating over months may not.
Presentation.
Beck's triad: hypotension, elevated jugular venous pressure, and muffled or distant heart sounds.
Pulsus paradoxus greater than 10 mmHg — an exaggerated inspiratory fall in systolic pressure.
Dyspnea worse when supine, tachycardia, tachypnea, narrowed pulse pressure, hepatomegaly, and cool extremities.
ECG: low QRS voltage and electrical alternans , the beat-to-beat variation in QRS amplitude produced by the heart swinging in fluid.
Chest radiograph: enlarged globular "water-bottle" cardiac silhouette.
Confirmation. Transthoracic echocardiography is the test of choice, showing effusion, right atrial collapse in systole, right ventricular collapse in early diastole, and respiratory variation across the mitral and tricuspid inflow.
Immediate management.
Urgent echocardiography-guided pericardiocentesis with placement of an indwelling drain.
Give volume — cautious normal saline supports preload in a preload-dependent state.
Avoid diuretics and vasodilators. This is the most commonly tested error: reducing preload in a patient whose obstructed ventricle depends on preload can precipitate cardiac arrest.
Avoid positive-pressure ventilation where possible before drainage; it further impedes venous return.
Definitive control for recurrent or loculated effusion: pericardial window or a sclerosing agent instilled into the pericardial space.
2. Malignant Airway Obstruction
Etiology. Endobronchial or tracheal tumor, extrinsic compression by mediastinal mass or adenopathy, or a mucus plug or clot in an already narrowed airway. Lung, esophageal, thyroid, and metastatic disease are typical causes.
Presentation. Progressive dyspnea, stridor (inspiratory with extrathoracic obstruction, expiratory with intrathoracic), wheeze localized to one side, cough, hemoptysis, post-obstructive pneumonia, and inability to lie flat. Stridor at rest signals critical narrowing.
Immediate management.
Position upright, supply oxygen, and keep the patient calm — agitation increases turbulent flow and worsens obstruction.
Heliox (helium-oxygen mixture) reduces turbulence and can buy time.
Corticosteroids (dexamethasone) reduce peritumoral edema.
Call interventional pulmonology or thoracic surgery immediately for rigid bronchoscopy with debulking, laser, cryotherapy, or airway stent placement.
Definitive therapy: external beam radiation, endobronchial brachytherapy, or systemic therapy for chemosensitive tumors.
Anterior mediastinal mass caution: these patients can lose their airway completely on induction of anesthesia or when placed supine. Avoid sedation, keep them upright, and involve anesthesia before any procedure.
3. Massive Hemoptysis
Definition. Expectoration of a volume large enough to threaten the airway — commonly defined as more than 100 to 600 mL in 24 hours, but any amount causing hypoxemia is treated as massive. Patients die of asphyxiation, not exsanguination .
Etiology. Cavitating squamous cell lung carcinoma, endobronchial tumor invading a bronchial artery, radiation necrosis, aspergilloma in a cavity, and anti-angiogenic therapy — bevacizumab is contraindicated in squamous NSCLC and in patients with cavitary lesions or prior significant hemoptysis for this reason.
Immediate management, in order.
Position the patient with the bleeding side down to protect the unaffected lung from soiling. This is the single most tested nursing action in this syndrome.
Secure the airway — suction, high-flow oxygen, and early intubation with a large-bore endotracheal tube if bleeding continues.
Large-bore intravenous access, type and cross, correct coagulopathy, and transfuse platelets if thrombocytopenic.
Urgent bronchoscopy for localization and local control, and bronchial artery embolization by interventional radiology as definitive control.
Consider radiation for tumor-related bleeding once acutely stabilized.
If bleeding is terminal and irreversible, transition to comfort-focused care with dark towels to reduce visual distress, and rapid-acting sedation such as intravenous or subcutaneous midazolam for the patient and support for the family.
4. Malignant Pleural Effusion
Presentation. Progressive dyspnea, dullness to percussion, absent breath sounds, decreased fremitus, and tracheal deviation away from the effusion when very large.
Diagnosis. Chest radiograph or ultrasound; thoracentesis with cytology (a single specimen is diagnostic in roughly 60% of cases, and yield rises with repeat sampling); exudative by Light's criteria.
Management.
Therapeutic thoracentesis for symptom relief. Remove no more than approximately 1.5 liters at one session , and stop earlier if the patient develops chest tightness or cough, to avoid re-expansion pulmonary edema .
For recurrent effusion: indwelling tunneled pleural catheter (allows home drainage and often produces spontaneous pleurodesis) or chemical pleurodesis with talc.
Pleurodesis fails when a trapped lung prevents pleural apposition; a tunneled catheter is preferred in that situation.
5. Carotid Blowout Syndrome
Setting. Head and neck cancer with prior radiation, radical neck dissection, flap necrosis, pharyngocutaneous fistula, or tumor invading the carotid.
Warning signs. A sentinel bleed from the mouth, nose, or wound; a pulsatile mass; exposed carotid in a wound bed. A sentinel bleed demands immediate vascular imaging — it precedes catastrophic rupture.
Immediate management. Direct pressure over the bleeding site, protect the airway, two large-bore intravenous lines, activate massive transfusion, and call interventional radiology emergently for embolization or covered stent placement. Where rupture is anticipated in a patient with terminal disease, an advance plan for comfort-focused management with immediate sedation should be documented in advance and dark towels kept at the bedside.
6. Pulmonary Embolism in the Patient With Cancer
Recognition. Sudden dyspnea, pleuritic chest pain, tachycardia, hypoxemia, hemoptysis, or syncope. Hypotension or right ventricular strain identifies massive or submassive PE.
Management. Anticoagulate as detailed in Section 10.5. Systemic thrombolysis is reserved for hemodynamically unstable massive PE, with catheter-directed therapy as an alternative when bleeding risk is high. Incidental PE found on staging imaging is treated the same as a symptomatic event.
The Common Thread
Every syndrome in this section is diagnosed clinically and confirmed by one specific test, and in each the immediate action differs from the definitive treatment. Tamponade needs volume and a needle, not a diuretic. Airway obstruction needs steroids, heliox, and a bronchoscopist, not more nebulizers. Massive hemoptysis needs the bleeding lung down and an airway, not a chest radiograph first. Knowing which lever to pull first is what the exam is testing.